Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT) Insider Trading
Directors, officers and holders of more than 10% of COGT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 60 transactions on file: 1 with code P, 5 with code S and 44 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Ferrante Karen Jean | Director | A Award | 759 | Not measured | Not measured |
| Jul 1, 2026 | Ferrante Karen Jean | Director | A Award | 627 | Not measured | Not measured |
| Jun 9, 2026 | Harwin Peter Evan | Director | A Award | 17,901 | Not measured | Not measured |
| Jun 9, 2026 | Ferrante Karen Jean | Director | A Award | 17,901 | Not measured | Not measured |
| Jun 9, 2026 | CAIN CHRISTOPHER W. | Director | A Award | 17,901 | Not measured | Not measured |
| Jun 9, 2026 | Morris Arlene | Director | A Award | 17,901 | Not measured | Not measured |
| Jun 9, 2026 | Shegog Todd | Director | A Award | 17,901 | Not measured | Not measured |
| Jun 9, 2026 | Ros Matthew | Director | A Award | 17,901 | Not measured | Not measured |
| May 19, 2026 | Robbins Andrew R | President and CEO | G Gift | 160,000 | Not measured | Not measured |
| May 19, 2026 | Robbins Andrew R | President and CEO | G Gift | 160,000 | Not measured | Not measured |
| Apr 1, 2026 | Ferrante Karen Jean | Director | A Award | 686 | Not measured | Not measured |
| Jan 22, 2026 | Fairmount Funds Management LLC | Director | S Sale | 3,500,000 | $36.40 | $127,400,000 |
| Jan 1, 2026 | Ferrante Karen Jean | Director | A Award | 643 | Not measured | Not measured |
| Dec 26, 2025 | Robinson John Edward | Chief Scientific Officer | S Sale | 90,000 | $38.74 | $3,486,600 |
| Dec 26, 2025 | Kearns Evan | Chief Legal Officer | S Sale | 65,000 | $38.70 | $2,515,500 |
| Dec 26, 2025 | Green John L. | Chief Financial Officer | S Sale | 77,000 | $38.68 | $2,978,360 |
| Dec 26, 2025 | Sachs Jessica | Chief Medical Officer | S Sale | 82,642 | $38.70 | $3,198,245 |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | F Tax Payment | 154,716 | $39.45 | $6,103,546 |
| Dec 17, 2025 | Robbins Andrew R | President and CEO | A Award | 245,000 | Not measured | Not measured |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | A Award | 55,000 | Not measured | Not measured |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | A Award | 65,000 | Not measured | Not measured |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | F Tax Payment | 125,602 | $39.45 | $4,954,999 |
| Dec 17, 2025 | Robbins Andrew R | President and CEO | A Award | 185,000 | Not measured | Not measured |
| Dec 17, 2025 | Robbins Andrew R | President and CEO | A Award | 840,000 | Not measured | Not measured |
| Dec 17, 2025 | Robbins Andrew R | President and CEO | F Tax Payment | 367,497 | $39.45 | $14,497,757 |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | A Award | 40,000 | Not measured | Not measured |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | A Award | 260,000 | Not measured | Not measured |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | A Award | 50,000 | Not measured | Not measured |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | A Award | 300,000 | Not measured | Not measured |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | F Tax Payment | 145,007 | $39.45 | $5,720,526 |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | A Award | 50,000 | Not measured | Not measured |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | A Award | 320,000 | Not measured | Not measured |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | F Tax Payment | 139,998 | $39.45 | $5,522,921 |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | A Award | 50,000 | Not measured | Not measured |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | A Award | 214,000 | Not measured | Not measured |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | F Tax Payment | 94,800 | $39.45 | $3,739,860 |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | A Award | 50,000 | Not measured | Not measured |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | A Award | 320,000 | Not measured | Not measured |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | A Award | 65,000 | Not measured | Not measured |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | A Award | 65,000 | Not measured | Not measured |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | A Award | 65,000 | Not measured | Not measured |
| Oct 1, 2025 | Ferrante Karen Jean | Director | A Award | 1,642 | Not measured | Not measured |
| Jul 10, 2025 | Fairmount Funds Management LLC | Director | P Purchase | 2,777,777 | $9.00 | $24,999,993 |
| Jul 1, 2025 | Ferrante Karen Jean | Director | A Award | 3,314 | Not measured | Not measured |
| Jun 4, 2025 | CAIN CHRISTOPHER W. | Director | A Award | 44,700 | Not measured | Not measured |
| Jun 4, 2025 | Ferrante Karen Jean | Director | A Award | 44,700 | Not measured | Not measured |
| Jun 4, 2025 | Morris Arlene | Director | A Award | 44,700 | Not measured | Not measured |
| Jun 4, 2025 | Harwin Peter Evan | Director | A Award | 44,700 | Not measured | Not measured |
| Jun 4, 2025 | Shegog Todd | Director | A Award | 44,700 | Not measured | Not measured |
| Jun 4, 2025 | Ros Matthew | Director | A Award | 44,700 | Not measured | Not measured |
The full Form 4 history is on the COGT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.